Pivagabine

	WikiDoc Resources for Pivagabine
Articles
Most recent articles on Pivagabine Most cited articles on Pivagabine Review articles on Pivagabine Articles on Pivagabine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pivagabine Images of Pivagabine Photos of Pivagabine Podcasts & MP3s on Pivagabine Videos on Pivagabine
Evidence Based Medicine
Cochrane Collaboration on Pivagabine Bandolier on Pivagabine TRIP on Pivagabine
Clinical Trials
Ongoing Trials on Pivagabine at Clinical Trials.gov Trial results on Pivagabine Clinical Trials on Pivagabine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pivagabine NICE Guidance on Pivagabine NHS PRODIGY Guidance FDA on Pivagabine CDC on Pivagabine
Books
Books on Pivagabine
News
Pivagabine in the news Be alerted to news on Pivagabine News trends on Pivagabine
Commentary
Blogs on Pivagabine
Definitions
Definitions of Pivagabine
Patient Resources / Community
Patient resources on Pivagabine Discussion groups on Pivagabine Patient Handouts on Pivagabine Directions to Hospitals Treating Pivagabine Risk calculators and risk factors for Pivagabine
Healthcare Provider Resources
Symptoms of Pivagabine Causes & Risk Factors for Pivagabine Diagnostic studies for Pivagabine Treatment of Pivagabine
Continuing Medical Education (CME)
CME Programs on Pivagabine
International
Pivagabine en Espanol Pivagabine en Francais
Business
Pivagabine in the Marketplace Patents on Pivagabine
Experimental / Informatics
List of terms related to Pivagabine

Pivagabine
Names
	IUPAC name 4-(2,2-Dimethylpropanoylamino)butanoic acid[citation needed]
Identifiers
CAS Number	69542-93-4 ;
3D model (JSmol)	Interactive image; Interactive image;
ChemSpider	62118 ;
ECHA InfoCard	Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG	D07342 ;
MeSH	N-trimethylacetyl-4-aminobutyric+acid
PubChem CID	68888;
UNII	C53SV0WO4V ;
	InChI InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12) Key: SRPNQDXRVRCTNK-UHFFFAOYSA-N ;
	SMILES CC(C)(C)c(:[o]):[nH]CCCc(:[o]):[oH]; CC(C)(C)C(=O)NCCCC(O)=O;
Properties
Chemical formula	C9H17NO3
Molar mass	187.24 g·mol−1
Related compounds
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	Infobox references

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pivagabine (Tonerg) is an antidepressant and anxiolytic drug which was introduced in Italy in 1997 for the treatment of depressive and maladaptive syndromes. But it was discontinued in Italy (according to Martindale). Originally believed to function as a prodrug to GABA,^[1] pivagabine is now believed to act via its inhibitory effects on corticotropin-releasing factor (CRF).^[2]^[3]^[4]^[5]

↑ Bianchi M, Quadro G, Mourier G, Galzigna L (1983). "Pharmacokinetics and in vitro effects of a 4-aminobutyric acid derivative with anticonvulsant action". Pharmacology. 27 (4): 237–40. doi:10.1159/000137876. PMID 6634934.
↑ Scapagnini U, Matera M (November 1997). "Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress". Arzneimittel-Forschung. 47 (11A): 1310–4. PMID 9450154.
↑ Esposito G, Luparini MR (November 1997). "Pivagabine: a novel psychoactive drug". Arzneimittelforschung. 47 (11A): 1306–9. PMID 9450153.
↑ Gerra G, Zaimovic A, Giusti F; et al. (July 2001). "Pivagabine effects on neuroendocrine responses to experimentally-induced psychological stress in humans". Behavioural Brain Research. 122 (1): 93–101. doi:10.1016/S0166-4328(01)00177-2. PMID 11287080.
↑ Serra M, Concas A, Mostallino MC; et al. (April 1999). "Antagonism by pivagabine of stress-induced changes in GABAA receptor function and corticotropin-releasing factor concentrations in rat brain". Psychoneuroendocrinology. 24 (3): 269–84. doi:10.1016/S0306-4530(98)00049-3. PMID 10101733.